Journal of Pharmacokinetics and Biopharmaceutics

, Volume 5, Issue 6, pp 579–596

The clinical pharmacokinetics of phenytoin

  • Ernst Martin
  • Thomas N. Tozer
  • Lewis B. Sheiner
  • Sidney Riegelman
Article

DOI: 10.1007/BF01059685

Cite this article as:
Martin, E., Tozer, T.N., Sheiner, L.B. et al. Journal of Pharmacokinetics and Biopharmaceutics (1977) 5: 579. doi:10.1007/BF01059685

Abstract

Procedures for estimating the variability in dosage requirements of phenytoin to achieve steadystate plasma concentrations of 10–20 mg/liter and for estimating the plasma concentrations produced on a fixed dose are given. Further, a method is proposed for estimating the dosage required to achieve a desired steady-state plasma phenytoin concentration when a steady-state value on a known daily dose has been measured, A method is also described for estimating dosage requirements when two or more plasma concentrations have been measured. These methods are derived from data obtained on administering phenytoin in four to five different dosage regimens until steady state was achieved in each of nine volunteers. The drug was administered orally as a suspension every 8 hr, starting with about 100mg/day. The daily dose was increased in steps, and maintained at each daily dose rate for 6–14 days, or longer. Blood samples were drawn 4 and 8 hr after the last dose on 2 successive days at the end of each step and analyzed for phenytoin concentration. The average of these values was used to estimate the steady-state plasma concentration, Cpss. For each subject the Cpss values were fitted to a rearranged Michaelis-Menten equation Cpss =KmR/(Vm-R). In this equation R is the dosing rate, Vm is the maximum rate of metabolism, and Km is a constant equal to the plasma concentration at which the metabolism rate is one-half maximum. The average values found for Vm and Km were 10.3 mg/kg/day and 11.54 mg/liter, respectively. The individual values of Vm and Km appear to be constant over time, but there is considerable interindividual variability: coefficients of variation are 25% and 50%, respectively.

Key words

phenytoinsteady statedosage requirementsdosage adjustmentcapacitylimited elimination

Copyright information

© Plenum Publishing Corporation 1977

Authors and Affiliations

  • Ernst Martin
    • 1
  • Thomas N. Tozer
    • 3
  • Lewis B. Sheiner
    • 1
    • 4
  • Sidney Riegelman
    • 3
  1. 1.Division of Clinical Pharmacology, Department of Medicine, School of MedicineUniversity of CaliforniaSan Francisco
  2. 2.Kinderspital ZürichZürichSwitzerland
  3. 3.Department of Pharmacy, School of PharmacyUniversity of CaliforniaSan Francisco
  4. 4.Department of Laboratory Medicine, School of MedicineUniversity of CaliforniaSan Francisco